Table 1.
Post liver transplantation outcomes for patients who have nonalcoholic fatty liver disease
| Ref. | Study size | NASH group survival (%) | Non-NASH group survival (%) | Study period |
| Malik et al[62] | 98 NASH | 30-d - 93.9 | 30-d - 94.4-98.0 | 1997-2008 |
| 686 Non-NASH group (PBC/PSC, ALD, HCV, CC) | 1-yr - 79.6 | 1-yr - 81.6-87.2 | ||
| 5-yr - 72.4 | 5-yr - 65.3-80.6 | |||
| Bhagat et al[63] | 71 NASH | 1-yr - 82 | 1-yr - 92 | 1997-2007 |
| 83 ALD | 5-yr - 75 | 5-yr - 86 | ||
| 9-yr - 62 | 9-yr - 76 | |||
| Barritt et al[64] | 21 NAFLD | 30-d - 80.9 | 30-d - 97 | 2004-2007 |
| 83 Non-NAFLD (ALD, HCV, HBV, PBC/PSC, AIH) | 1-yr - 76.2 | 1-yr - 89.5 | ||
| 3-yr - 76.2 | 3-yr - 83.5 | |||
| Agopian et al[65] | 144 NASH | 90-d - 90 | 90-d - 90-96 | 1993-2011 |
| 1150 Non-NASH (HBV, HCV, ALD, CC, PBC/PSC) | 1-yr - 84 | 1-yr - 79-87 | ||
| 5-yr - 75 | 5-yr - 54-70 | |||
| Kennedy et al[66] | 129 NASH | 1-yr - 90 | 1-yr - 92 | 1999-2009 |
| 775 Non-NASH - etiologies not defined | 3-yr - 88 | 3-yr - 86 | ||
| 5-yr - 85 | 5-yr - 80 | |||
| Park et al[67] | 71 NASH | 1-yr - 78 | 1-yr - 87 | 1998-2008 |
| 472 Non-NASH | 2-yr - 78 | 2-yrs - 85 | ||
| Vanwagner et al[44] | 115 NASH | 1-yr - 81.3 | 1-yr - 88.1 | 1993-2010 |
| 127 ALD | 3-yr - 73.3 | 3-yr - 85.3 | ||
| 5-yr - 60.3 | 5-yr - 68.8 | |||
| Afazali et al[68] | 1810 NASH | 1-yr - 87.6 | Variable | 1997-2010 |
| 3843 CC | 3-yr - 82.2 | |||
| 48.085 Non-NASH | 5-yr - 76.7 | |||
| Charlton et al[14] | 1959 NASH | 1-yr - 84 | 1-yr - 87 | 2001-2009 |
| 33822 Non-NASH | 3-yr - 78 | 3-yr - 78 |
NAFLD: Nonalcoholic fatty liver disease; ALD: Alcoholic liver disease; HCV: Hepatitis C virus; HBV: Hepatitis B virus; CC: Cryptogenic cirrhosis; PBC: Primary biliary cirrhosis; PSC: Primary sclerosing cholangitis.